BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35882665)

  • 1. Sleep-controlling neurons are sensitive and vulnerable to multiple forms of α-synuclein: implications for the early appearance of sleeping disorders in α-synucleinopathies.
    Dos Santos AB; Skaanning LK; Thaneshwaran S; Mikkelsen E; Romero-Leguizamón CR; Skamris T; Kristensen MP; Langkilde AE; Kohlmeier KA
    Cell Mol Life Sci; 2022 Jul; 79(8):450. PubMed ID: 35882665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein Responses in the Laterodorsal Tegmentum, the Pedunculopontine Tegmentum, and the Substantia Nigra: Implications for Early Appearance of Sleep Disorders in Parkinson's Disease.
    Dos Santos AB; Skaanning LK; Mikkelsen E; Romero-Leguizamón CR; Kristensen MP; Klein AB; Thaneshwaran S; Langkilde AE; Kohlmeier KA
    J Parkinsons Dis; 2021; 11(4):1773-1790. PubMed ID: 34151857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent neuronal effects of α-synuclein reveal that GABAergic transmission is neuroprotective of sleep-controlling neurons.
    Santos ABD; Thaneshwaran S; Ali LK; Leguizamón CRR; Wang Y; Kristensen MP; Langkilde AE; Kohlmeier KA
    Cell Biosci; 2023 Sep; 13(1):172. PubMed ID: 37710341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-dependent effects of monomeric α-synuclein on calcium and cell death of lateral hypothalamic mouse neurons are altered by orexin.
    Bohid S; Ali LK; Romero-Leguizamón CR; Langkilde AE; Dos Santos AB; Kohlmeier KA
    Mol Cell Neurosci; 2024 Jun; 129():103934. PubMed ID: 38701995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.
    Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.
    Karpowicz RJ; Haney CM; Mihaila TS; Sandler RM; Petersson EJ; Lee VM
    J Biol Chem; 2017 Aug; 292(32):13482-13497. PubMed ID: 28611062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.
    Calabresi P; Mechelli A; Natale G; Volpicelli-Daley L; Di Lazzaro G; Ghiglieri V
    Cell Death Dis; 2023 Mar; 14(3):176. PubMed ID: 36859484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions.
    De Giorgi F; Abdul-Shukkoor MB; Kashyrina M; Largitte LA; De Nuccio F; Kauffmann B; Lends A; Laferrière F; Bonhommeau S; Lofrumento DD; Bousset L; Bezard E; Buffeteau T; Loquet A; Ichas F
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons.
    Froula JM; Henderson BW; Gonzalez JC; Vaden JH; Mclean JW; Wu Y; Banumurthy G; Overstreet-Wadiche L; Herskowitz JH; Volpicelli-Daley LA
    Acta Neuropathol Commun; 2018 May; 6(1):35. PubMed ID: 29716652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
    Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
    J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GV-971 attenuates α-Synuclein aggregation and related pathology.
    Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein Induces Progressive Changes in Brain Microstructure and Sensory-Evoked Brain Function That Precedes Locomotor Decline.
    Chu WT; DeSimone JC; Riffe CJ; Liu H; Chakrabarty P; Giasson BI; Vedam-Mai V; Vaillancourt DE
    J Neurosci; 2020 Aug; 40(34):6649-6659. PubMed ID: 32669353
    [No Abstract]   [Full Text] [Related]  

  • 16. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.
    Karpowicz RJ; Trojanowski JQ; Lee VM
    Lab Invest; 2019 Jul; 99(7):971-981. PubMed ID: 30760864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
    Benskey MJ; Perez RG; Manfredsson FP
    J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
    Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
    Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.